直通電訊(08337.HK)與密卡思組合營 發展政府數字化解決方案
直通電訊(08337.HK)公布,與密卡思訂立框架協議,雙方擬於香港組成合資公司。
合資將為世界各地各行各業、政府以及其他公共機構及社區的數字化致力提供全面解決方案。一方面,合資公司將從密卡思取得5G小型基站射頻單元的集成芯片及解決方案。另一方面,合資公司將憑著公司與海外及中國國內電訊行業運營商及專業管理團隊的強大關係的優勢,拓展全球5G基建行業的其他商機。
合資公司須設有已發行股本為10萬元,公司佔40%,而密卡思的全資為30%,餘下30%為張日(方土方)牽頭的高級管理團隊持有。密卡思為中國主要業務為研發5G小型基站射頻單元的核心集成芯片企業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.